Laserfiche WebLink
Schedule A <br />Core Strategies <br />States and Qualifying Block Grantees shall choose from among the abatement strategies listed in <br />Schedule B. However, priority shall be given to the following core abatement strategies ("Core <br />Strategies")[, such that a minimum of _% of the [aggregate] state -level abatement distributions shall <br />be spent on [one or more of] them annually].' <br />A. Naloxone or other FDA -approved drug to reverse opioid overdoses <br />1. Expand training for first responders, schools, community support groups and families; and <br />2. Increase distribution to individuals who are uninsured or whose insurance does not cover the needed <br />service. <br />B. Medication -Assisted Treatment ("MAT") Distribution and other opioid -related treatment <br />1. Increase distribution of MAT to non -Medicaid eligible or uninsured individuals; <br />2. Provide education to school-based and youth -focused programs that discourage or prevent misuse; <br />3. Provide MAT education and awareness training to healthcare providers, EMTs, law enforcement, <br />and other first responders; and <br />4. Treatment and Recovery Support Services such as residential and inpatient treatment, intensive <br />outpatient treatment, outpatient therapy or counseling, and recovery housing that allow or integrate <br />medication with other support services. <br />C. Pregnant & Postpartum Women <br />1. Expand Screening, Brief Intervention, and Referral to Treatment ("SBIRT") services to non - <br />Medicaid eligible or uninsured pregnant women; <br />2. Expand comprehensive evidence -based treatment and recovery services, including MAT, for women <br />with co-occurring Opioid Use Disorder ("OUD") and other Substance Use Disorder ("SUD")/Mental <br />Health disorders for uninsured individuals for up to 12 months postpartum; and <br />3. Provide comprehensive wrap-around services to individuals with Opioid Use Disorder (OUD) <br />including housing, transportation, job placement/training, and childcare. <br />D. Expanding Treatment for Neonatal Abstinence Syndrome <br />1. Expand comprehensive evidence -based and recovery support for NAS babies; <br />2. Expand services for better continuum of care with infant -need dyad; and <br />3. Expand long-term treatment and services for medical monitoring of NAS babies and their families. <br />I As used in this Schedule A, words like "expand," "fund," "provide" or the like shall not indicate a preference for new or <br />existing programs. Priorities will be established through the mechanisms described in the Term Sheet. <br />1 <br />